Skip to main content

Advertisement

SpringerLink
Log in

Features and Management of Colonic Diverticular Disease

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Diverticular disease is one of the most prevalent gastrointestinal conditions to afflict Western populations. Although the majority of patients with diverticulosis remain asymptomatic, about one third will develop symptoms at some point in their lives. Symptomatic diverticular disease can range from chronic mild gastrointestinal distress to acute bouts of diverticulitis complicated by abscess or frank colonic perforation. The mainstay of treatment of symptomatic diverticular disease has long been bowel rest, antibiotics, and pain control, reserving surgery for those with complicated disease. This review discusses the epidemiology, pathophysiology, clinical presentation, and management of the spectrum of diverticular disease, including recent advances in the treatment of chronic diverticular disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Painter NS, Burkitt DP: Diverticular disease of the colon: a deficiency disease of Western civilization. Br Med J 1971, 2:450–454.

    Article  CAS  PubMed  Google Scholar 

  2. Peppercorn MA: The overlap of inflammatory bowel disease and diverticular disease. J Clin Gastroenterol 2004, 38(Suppl):S8–S10.

    Article  PubMed  Google Scholar 

  3. DiMario F, Comparato G, Fanigliulo L, et al.: Use of mesalazine in diverticular disease. J Clin Gastroenterol 2006, 40(Suppl 3):S155–S159.

    Article  CAS  Google Scholar 

  4. Floch MH, White JA: Management of diverticular disease is changing. World J Gastroenterol 2006, 12:3225–3228.

    PubMed  Google Scholar 

  5. Sheth A, Longo W, Floch M: Diverticular disease and diverticulitis. Am J Gastroenterol 2008, 103:1–7.

    Article  Google Scholar 

  6. Hughes LE: Postmortem survey of diverticular disease of the colon. I Diverticulosis and diverticultis. Gut 1969, 10:336–344.

    Article  CAS  PubMed  Google Scholar 

  7. • Etzioni DA, Mack TM, Kaiser AM, et al.: Diverticulitis in the United States: 1998–2005: changing patterns of disease and treatment. Ann Surg 2009, 249:210–217. This is the first study to report dramatic changes in rates of treatment for diverticulitis in the United States, including increased rates of elective surgeries and shift toward those of younger age.

    Article  PubMed  Google Scholar 

  8. West AB, Losada M: The pathology of diverticulosis coli. J Clin Gastroenterol 2004, 38(Suppl):S11–S16.

    Article  PubMed  Google Scholar 

  9. Burkitt D: Diverticular disease of the colon epidemiological evidence relating it to fibre-depleted diets. Trans Med Soc Lond 1973, 89:81–84.

    CAS  PubMed  Google Scholar 

  10. Painter NS, Truelove SC, Ardan GM, et al.: Segmentation and the localization of intraluminal pressure in the human colon, with special reference to the pathogenesis of colinic diverticula. Gastroenterology 1968, 54(Suppl):778–780.

    PubMed  Google Scholar 

  11. • Strate LL, Lin YL, Syngal S, et al.: Nut, corn and popcorn consumption and the incidence of diverticular disease. JAMA 2008, 300:907–914. This article reports a large, prospective study of men without known diverticular disease, showing that nut, corn, and popcorn consumption did not increase the risk of diverticulosis or diverticular complications, thus questioning the long-standing recommendation to avoid such foods to prevent diverticular complications.

    Article  CAS  PubMed  Google Scholar 

  12. Floch CL: Diagnosis and management of acute diverticulitis. J Clin Gastroenterol 2006, 40(Suppl 3):S136–S144.

    Article  PubMed  Google Scholar 

  13. • Simpson J, Sundler F, Spiller RC, et al.: Post inflammatory damage to the enteric nervous system in diverticular disease and its relationship to symptoms. Neurogastroenterol Motil 2009, 21:847–858. This article describes a recent study clearly showing important alterations in the enteric nervous system, including—for the first time—a selective increase in a range of neuropeptides, which can be related to the presence of symptoms in patients with diverticulitis.

    Article  CAS  PubMed  Google Scholar 

  14. Tursi A: New physiopathological and therapeutic approaches to diverticular disease of the colon. Expert Opin Pharmacother 2007, 8:299–307.

    Article  CAS  PubMed  Google Scholar 

  15. Kohler L, Sauerland S, Neugebauer E: Diagnosis and treatment of diverticular disease: Results of a consensus development conference.The Scientific Committee of the European Association for Endoscopic Surgery. Surg Endosc 1999, 13:430–436.

    Article  CAS  PubMed  Google Scholar 

  16. Jacobs D: Diverticulitis. N Engl J Med 2007, 357:2057–2066.

    Article  CAS  PubMed  Google Scholar 

  17. Kaiser A, Jiang J, Lake J, et al.: The management of complicated diverticulitis and the role of computed tomography. Am J Gastroenterol 2005, 100:910–917.

    Article  PubMed  Google Scholar 

  18. Antolovic D, Reissfelder C, Weitz J, et al.: Surgical treatment of sigmoid diverticulitis—analysis or predictive risk factors for postoperative infections, surgical complications, and mortality. Int J Colorectal Dis 2009, 24:577–584.

    Article  CAS  PubMed  Google Scholar 

  19. Ravo B, Khan SA, Ger R, et al.: Unusual extraperitoneal presentations of diverticulitis. Am J Gastroenterol 1985, 80:346–351.

    CAS  PubMed  Google Scholar 

  20. Najjar SF, Jamal MK, Savas JF, et al.: The spectrum of colovesical fistula and diagnostic paradigm. Am J Surg 2004, 188:617.

    Article  PubMed  Google Scholar 

  21. Bordeianou L, Hodin R: Controversies in the surgical management of sigmoid diverticulitis. J Gastrointest Surg 2007, 11:542–548.

    Article  PubMed  Google Scholar 

  22. Melchior S, Cudovic D, Thuroff J, et al.: Diagnosis and surgical management of colovesical fistulas due to sigmoid diverticulitis. J Urol 2009, 182:978–982.

    Article  PubMed  Google Scholar 

  23. Tyau ES, Prystowsky JB, Joehl RJ, et al.: Acute diverticulitis. A complicated problem in the immunocompromised patient. Arch Surg 1991, 11:542–548.

    Google Scholar 

  24. Saltzman DJ, Williams RA, Gelfand DV, et al.: The surgeon and AIDS: twenty years later. Arch Surg 2005, 140:961–967.

    Article  PubMed  Google Scholar 

  25. Frattini J, Longo WE: Diagnosis and treatment of chronic and recurrent diverticulitis. J Clin Gastroenterol 2006, 40(Suppl 3):S145–S149.

    Article  PubMed  Google Scholar 

  26. • Jung H, Choung RS, Talley NJ, et al.: Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study. Am J Gastroenteol 2010, 105:652–661. This article describes a large, population-based, cross-sectional study that demonstrated for the first time the association of IBS and colonic diverticular disease; the association was strongest in older people.

    Article  Google Scholar 

  27. Clemens CH, Samsom M, Smout AJ, et al.: Colorectal visceral perception in diverticular disease. Gut 2004, 53:717–722.

    Article  CAS  PubMed  Google Scholar 

  28. Spiller R: How inflammation changes neuromuscular function and its relevance to symptoms in diverticular disease. J Clin Gastroenterol 2006, 40(Suppl):S117–S120.

    Article  PubMed  Google Scholar 

  29. Mayer EA, Collins SM: Evolving pathophsyologic models of functional gastrointestinal disorders. Gastroenterology 2002, 122:2032–2048.

    Article  PubMed  Google Scholar 

  30. Costedio MM, Coates MD, Hyman NH, et al.: Serotonin signaling in diverticular disease. J Gastrointest Surg 2008, 12:1439–1445.

    Article  PubMed  Google Scholar 

  31. Bassotti G, Battaglia E, DeRoberto G, et al.: Alterations in colonic motility and relationship to in pain in colonic diverticulosis. Clin Gastroenterol Hepatol 2005, 3:248–253.

    Article  PubMed  Google Scholar 

  32. Tursi A: Mesalazine for diverticular disease of the colon—a new role for an old drug. Expert Opin Pharmacother 2005, 6:69–74.

    Article  CAS  PubMed  Google Scholar 

  33. Goldstein NS, Leon-Armin C, Mani A: Crohn's colitis-like changes in sigmoid diverticulitis specimens is usually an idosyncratic inflammatory response to the diverticulosis rather than Crohn's colitis. Am J Surg Pathol 2000, 24:668–75.

    Article  CAS  PubMed  Google Scholar 

  34. Tursi A, Brandimarte G, Aiello F, et al.: Assessment and grading of mucosal inflammation in colonic diverticular disease. Clin Gastroenterol 2008, 42:699–703.

    Article  Google Scholar 

  35. • Tursi A, Brandimarte G, Aiello F, et al.: Faecal calprotectin in colonic diverticular disease: a case-control study. Int J Colorectal Dis 2009, 24:49–55. Because symptomatic uncomplicated DD and IBS share most symptoms, this important study suggests for the first time that fecal calprotectin may be a tool in differentiating symptomatic uncomplicated DD from IBS.

    Article  PubMed  Google Scholar 

  36. Gore S, Shepherd NA, Wilkinson SP: Endoscopic crescentic fold disease of the sigmoid colon: the clinical and histopathological spectrum of a distinct endoscopic appearance. Int J Colorectal Dis 1992, 7:76–81.

    Article  CAS  PubMed  Google Scholar 

  37. Jani N, Finkelstein S, Blumberg D, et al.: Segmental colitis associated with diverticulosis. Dig Dis Sci 2002, 47:1175–1181.

    Article  PubMed  Google Scholar 

  38. Lamps LW, Knapple WL: Diverticular disease-associated colitis. Clin Gastroenterol Hepatol 2007, 5:27–31.

    Article  PubMed  Google Scholar 

  39. Pereira MC: Diverticular disease-associated colitis: progression to severe chronic ulcerative colitis after sigmoid surgery. Gastrointest Endosc 1998, 48:520–523.

    Article  CAS  PubMed  Google Scholar 

  40. Ierardi E, Meucci G, Hassan C, et al.: Tumour necrosis factor alpha in segmental colitis associated with diverticula. Dig Dis Sci 2008, 53:1865–1868.

    Article  CAS  PubMed  Google Scholar 

  41. Hassan C, Zullo A, Morini S, et al.: Tumour necrosis factor alpha downregulation and therapeutic response to infliximab in a case of segmental colitis associated with diverticula. Gut 2006, 55:589–590.

    Article  CAS  PubMed  Google Scholar 

  42. Rafferty J, Shellito P, Hyman N, et al.: Practice parameters for sigmoid diverticulitis. Dis Colon Rectum 2006, 49:939–944.

    Article  PubMed  Google Scholar 

  43. Stollman N, Raskin J: Diagnosis and management of diverticular disease of the colon in adults. Ad Hoc Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1999, 94:3110–3121.

    Article  CAS  PubMed  Google Scholar 

  44. Wolff B, Devine R: Surgical management of diverticulitis. Am Surg 2000, 66:153–156.

    CAS  PubMed  Google Scholar 

  45. Wong WD, Wexner SD, Lowry A, et al.: Practice parameters for the treatment of sigmoid diverticulitis—supporting documentation. The Standards Task Force. The American Society of Colon and Rectal Surgeons. Dis Colon Rectum 2000, 43:290–297.

    Article  CAS  PubMed  Google Scholar 

  46. Salem L, Veenstra DL, Sullivan SD, et al.: The timing of elective colectomy in diverticulitis: a decision analysis. J Am Coll Surg 2004, 199:904–912.

    Article  PubMed  Google Scholar 

  47. Wasvary H, Turfah F, Kadro O, et al.: Same hospitalization resection for acute diverticulitis. Am Surg 1999, 65:632–635.

    CAS  PubMed  Google Scholar 

  48. Constantinides VA, Tekkis PP, Athanasiou T, et al.: Primary resection with anastomosis versus Hartmann's procedure in nonelective surgery for acute colonic diverticulitis: a systematic review. Dis Colon Rectum 2006, 49:966–981.

    Article  PubMed  Google Scholar 

  49. Reissfelder C, Buhr HJ, Ritz JP: What is the optimal time of surgical intervention after an acute attack of sigmoid diverticulitis: early or late elective laparoscopic resection? Dis Colon Rectum 2006, 49:1842–1848.

    Article  PubMed  Google Scholar 

  50. Parks T: Natural history of diverticular disease of the colon. A review of 521 cases. BMJ 1969, 4:639–642.

    Article  CAS  PubMed  Google Scholar 

  51. Chapman J, Davies M, Wolff B, et al.: Complicated diverticulitis: is it time to rethink the rules? Ann Surg 2005, 242:576.

    PubMed  Google Scholar 

  52. Vargas HD, Ramirez RT, Hoffman GC, et al.: Defining the role of laparoscopic-assisted sigmoid colectomy for diverticulitis. Dis Colon Rectum 2000, 43:1726.

    Article  CAS  PubMed  Google Scholar 

  53. • Klarenbeek B, Veenhof A, Bergamaschi R, et al.: Laparoscopic sigmoid resection for diverticulitis decreases major morbidity rates: a randomized control trial: short-term results of the Sigma Trial. Ann Surg 2009, 249:39–44. This article reports the first randomized trial showing laparoscopic sigmoid resection is associated with reduction in major complication rates, less pain, improved quality of life, and shorter hospitalization.

    Article  PubMed  Google Scholar 

  54. Russ AJ, Obma KL, Kennedy GD, et al.: Laparoscopy improves short-term outcomes after surgery for diverticular disease. Gastroenterology 2010, 138:2267–2274, 2274.e1.

    Article  PubMed  Google Scholar 

  55. Konvolinka CW: Acute diverticulitis under age forty. Am J Surg 1994, 167:562–565.

    Article  CAS  PubMed  Google Scholar 

  56. Cunningham MA, Davis JW, Kaups KL: Medical versus surgical management of diverticulitis in patients under age 40. Am J Surg 1997, 174:733–735.

    Article  CAS  PubMed  Google Scholar 

  57. Ambrosetti P, Robert J, Witzig J, et al.: Incidence, outcome, and proposed management of isolated abscesses complicating acute left-sided colonic diverticulitis. A prospective study of 140 patients. Dis Colon Rectum 1992, 35:1072–1076.

    Article  CAS  PubMed  Google Scholar 

  58. Janes S, Meagher A, Frizelle FA: Elective surgery after acute diverticulitis. Br J Surg 2005, 92:133–142.

    Article  CAS  PubMed  Google Scholar 

  59. Guzzo J, Hyman N: Diverticulitis in young patients: is resection after a single attack always warranted? Dis Colon Rectum 2004, 47:1187.

    Article  PubMed  Google Scholar 

  60. Omparato G, Fanigliulo L, Di Mario F, et al.: Quality of life in uncomplicated symptomatic diverticular disease: is it another good reason for treatment? Dig Dis 2007, 25:252–259.

    Article  Google Scholar 

  61. Brandimarte G, Tursi A: Rifaximin plus mesalazine followed by mesalazine alone is highly effective in obtaining remission of symptomatic uncomplicated diverticular disease. Med Sci Monit 2004, 10:P170–P173.

    CAS  Google Scholar 

  62. Tursi A, Brandimarte G, Daffina R: Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon. Dig Liver Dis 2002, 34:510–515.

    Article  CAS  PubMed  Google Scholar 

  63. Tursi A, Brandimarte G, Giorgetti GM, et al.: Continuous versus cyclic mesalazine therapy for patients affected by recurrent symptomatic uncomplicated diverticular disease of the colon. Dig Dis Sci 2007, 52:671–674.

    Article  CAS  PubMed  Google Scholar 

  64. Colecchia A, Sandri L, Capodicasa S, et al.: Diverticular disease of the colon: new perspectives in symptom development and treatment. World J Gastroenterol 2003, 9:1385–1389.

    PubMed  Google Scholar 

  65. Giaccari S, Tronci S, Ferrieri A, et al.: Long-term treatment with rifaximn and lactobacilli in post-diverticulitic stenoses of the colon. Riv Eur Sci Med Farmacol 1993, 15:29–34.

    CAS  PubMed  Google Scholar 

  66. Tursi A, Brandimarte G, Giogetti GM, et al.: Mesalazine and or lactobacillus in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective randomized, open-label study. J Clin Gastroenterol 2006, 40:312–316.

    Article  PubMed  Google Scholar 

  67. Fric P, Zavoral M: The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur J Gastroenterol Hepatol 2003, 15:313–315.

    Article  PubMed  Google Scholar 

  68. Tursi A, Brandimarte G, Giorgetti GM, et al.: Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon. Int J Colorectal Dis 2007, 22:1103–1108.

    Article  PubMed  Google Scholar 

  69. • Trivedi CD, Das KM: Emerging therapies for diverticular disease of the colon. J Clin Gastroenterol 2008, 42:1145–1151. This article is a well-written review of the evidence supporting some conventional and emerging therapies for DD and a proposed evidence-based algorithmic approach to the treatment of DD.

    Article  PubMed  Google Scholar 

  70. Papi C, Ciaco A, Koch M, et al.: Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multi-centre open trial. Diverticular Disease Study Group. Ital J Gastroenterol 1992, 24:452–456.

    CAS  PubMed  Google Scholar 

  71. Papi C, Ciaco A, Koch M, et al.: Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Aliment Pharmacol Ther 1995, 9:33–39.

    Article  CAS  PubMed  Google Scholar 

  72. Latella G, MT PMT, Sottili S, et al.: Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis 2003, 18:55–62.

    Article  PubMed  Google Scholar 

  73. D’Inca R, Pomerri F, Vettorato M, et al.: Interaction between rifaximin and dietary fibre in patients with diverticular disease. Aliment Pharmacol Ther 2007, 25:771–779.

    Article  PubMed  Google Scholar 

  74. Colecchia A, Vestito A, Pasqui F, et al.: Efficacy of long term cyclic administration of the poorly absorbed antibiotic rifaximin in symptomatic, uncomplicated colonic diverticular disease. World J Gastroenterol 2007, 13:264–269.

    CAS  PubMed  Google Scholar 

Download references

Disclosure

No potential conflict of interest relevant to this article was reported.

Author information

Authors and Affiliations

  1. Yale University School of Medicine, Section of Digestive Disease, New Haven, CT, 06510, USA

    Jason Hemming & Martin Floch

Authors
  1. Jason Hemming
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martin Floch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jason Hemming.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hemming, J., Floch, M. Features and Management of Colonic Diverticular Disease. Curr Gastroenterol Rep 12, 399–407 (2010). https://doi.org/10.1007/s11894-010-0126-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-010-0126-z

Keywords

Search

Navigation